Multiplex Respiratory Antigen Test: Accelerating IVDR Market Access

Read more

Get in touch

Global in vitro diagnostics (IVD) manufacturer

Clinical

In vitro Diagnostics

Get in touch

Share

\ \ X (Twitter) \ \ LinkedIn \ \ WhatsApp \ \ Copy link \ \ Mail

Our client is a global leader in IVD, specializing in molecular diagnostic platforms and point-of-care testing solutions. With a strong foothold in infectious disease diagnostics, they are actively expanding their molecular testing portfolio across Europe, bringing innovative tools to meet evolving healthcare needs.

Read more

1

Challenge

2

Approach

3

Result

Challenge

The client developed a multiplex respiratory antigen assay designed for rapid detection of multiple common respiratory viruses from a single nasal or nasopharyngeal swab. Intended for professional and near-patient use, this test offers the advantage of quickly differentiating key respiratory infections on a single device.

Their urgent goal was to secure CE-marking under the IVDR framework as fast as possible, aiming to launch ahead of the upcoming respiratory virus season. The shifting landscape, moving beyond COVID-19 to broader respiratory panels, meant timing was critical for maintaining a competitive edge and supporting public health efforts.

However, the client faced regulatory uncertainty. While COVID-19 was classified as Class D with specific common specifications, the other respiratory analytes fell under different rules, complicating the path to compliance.

Approach

QbD Group developed a focused IVDR clinical plan that balanced strict regulatory requirements with the need for speed. We designed a tailored performance evaluation to generate solid clinical data within a tight timeline.

Leveraging our strong network of study sites, we quickly identified locations capable of handling both professional and near-patient testing during the busy respiratory season. We managed ethical approvals, contracts, and logistics efficiently to launch the study without delay.

Throughout the process, we maintained close oversight, tracking progress and addressing challenges promptly. Clear communication and agile decisions helped us navigate the regulatory landscape smoothly.

Result

Our flexible and proactive approach enabled the client to gather the necessary clinical evidence for IVDR CE-marking right on schedule. Thanks to our wide-reaching clinical partnerships, sample collection was fast-tracked, taking full advantage of the respiratory season peak.

The collaborative and adaptive project management style ensured that every regulatory and operational milestone was met promptly. This timely delivery empowered the client to launch a distinct respiratory testing solution in Europe, strengthening their position as an innovation frontrunner during a critical period for public health.

Get in touch

Have a complex diagnostic or IVDR challenge you want to tackle quickly and confidently?

Reach out to our experts today, we’re here to help you navigate regulatory hurdles and bring your innovation to market on time.

First name*

Last name*

Professional Email*

Company name*

Role*

Please SelectC-level / VPDirector(Sr.) ManagerSpecialist/AnalystIntern/ApprenticeIndividual contributorOther

Department*

Please SelectStrategy & ManagementRegulatory & VigilanceQuality Assurance & ControlIT & Digital InnovationManufacturing & ProductionProduct DevelopmentResearch & InnovationClinical Affairs & OperationsMedical AffairsMarket AccessSales & MarketingHRProcurementOther

(Mobile) phone number

Country*

Please SelectAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAsia/Pacific RegionAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCote d'IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaEuropeFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern and Antarctic LandsGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Industry *

Please SelectMedical DevicesIn Vitro DiagnosticsPharmaBiotechAnimal HealthService providerConsumer HealthOther

Question submitted*

Field of Interest at time of last SRA

Content Title

Content Type

Content Division

QbD Group is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

• Yes, I want to stay informed on the latest industry trends and updates

• I consent to the privacy policy and understand that my personal data will be stored and processed *